HLA-DQ restricted activation of nitroso-sulfamethoxazole-specific CD4+ T-lymphocytes

Documenti analoghi

• Abs No: HLA-A*31:01 positive hypersensitive patient
  di: Lichtenfels, Maike, et al.
  Pubblicazione: (2014)
• Identification of susceptible HLA class II co-amoxiclav genotypes based on the analysis of drug-specific T-cells from patients with liver injury
  di: Saide, Katy, et al.
  Pubblicazione: (2014)
• Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
  di: Faulkner, Lee, et al.
  Pubblicazione: (2014)
• Negative regulation by PD-L1 during drug-specific priming of IL-22 secreting T-cells and the influence of PD-1 on effector T-cell function
  di: Gibson, Andrew, et al.
  Pubblicazione: (2014)
• Negative regulation by Programmed Death Ligand-1 during drug-specific priming of T-cells and the influence of Programmed Death-1 on effector T-cell function
  di: Gibson, Andrew, et al.
  Pubblicazione: (2014)